Reto Lang
Reto Lang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Volker Thiel
Affiliations Institute of Virology and Immunology (IVI), Bern and Mittelhäusern, Switzerland, Department of Infectious Diseases and Pathobiology (DIP), Vetsuisse Faculty, University of Bern, Bern, Switzerland, Multidisciplinary Center for Infectious Diseases (MCID), University of Bern, Bern, Switzerland
3 shared publications - Guliz Tuba Barut
Institute of Virology and Immunology
2 shared publications - Jenna Nicole Kelly
Institute of Virology and Immunology, Bern and Mittelhäusern, Bern, Switzerland
2 shared publications - Lisa Thomann
Institute of Virology and Immunology, Bern and Mittelhäusern
2 shared publications - Annika Kratzel
Institute of Virology and Immunology, Bern and Mittelhäusern, Bern, Switzerland
1 shared publication Claudia Kristen-Burmann
Institute of Virology, Justus Liebig University Giessen, Giessen, Germany
1 shared publication
Latest Publications
- 3 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (45) , 41717-41726
Photoswitchable RNA Degraders for Spatiotemporal Activation of Host-Directed Antivirals in Mammalian Cells
Strategies to develop broad-spectrum antivirals are highly sought after. A promising modern approach includes recruitment of host proteins as a means of activating immune responses that target multiple virus families. Host-directed therapies require a balance of antiviral effects and immunopathology. Herein, a known RNase L ligand was retrofitted with a hemithioindigo photoswitch to obtain a novel light-activatable pyrazol-hemithioindigo pharmacophore. This newly developed class of RNase L ligands allows spatiotemporal control of RNA degradation with isolated enzyme as well as in human cancer cells and virus infected cells. This work showcases the implementation of photopharmacology to elicit antiviral effects as potential strategy to limit off-site toxicity stemming from RNA degradation. The designed photoswitches provide a tool to study exogenous, conditional activation of RNase L for the development of broad-spectrum antivirals.
- 3 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (45) , 41717-41726
Photoswitchable RNA Degraders for Spatiotemporal Activation of Host-Directed Antivirals in Mammalian Cells
Strategies to develop broad-spectrum antivirals are highly sought after. A promising modern approach includes recruitment of host proteins as a means of activating immune responses that target multiple virus families. Host-directed therapies require a balance of antiviral effects and immunopathology. Herein, a known RNase L ligand was retrofitted with a hemithioindigo photoswitch to obtain a novel light-activatable pyrazol-hemithioindigo pharmacophore. This newly developed class of RNase L ligands allows spatiotemporal control of RNA degradation with isolated enzyme as well as in human cancer cells and virus infected cells. This work showcases the implementation of photopharmacology to elicit antiviral effects as potential strategy to limit off-site toxicity stemming from RNA degradation. The designed photoswitches provide a tool to study exogenous, conditional activation of RNase L for the development of broad-spectrum antivirals.
- Open Access
- 20 February 2024
- Published by American Society for Microbiology in Journal of Virology
- Vol. 98 (2) , e0121623
An RNA replicon system to investigate promising inhibitors of feline coronavirus
FIPV is of great significance in the cat population around the world, causing 0.3%–1.4% of feline deaths in veterinary practices (2). As there are neither effective preventive measures nor approved treatment options available, there is an urgent need to identify antiviral drugs against FIPV. Our FCoV replicon system provides a valuable tool for drug discovery in vitro . Due to the lack of cell culture systems for serotype I FCoVs (the serotype most prevalent in the feline population) (2), a different system is needed to study these viruses. A viral replicon system is a valuable tool for studying FCoVs. Overall, our results demonstrate the utility of the serotype I feline coronavirus replicon system for antiviral screening as well as to study this virus in general. We propose several compounds representing promising candidates for future clinical trials and ultimately with the potential to save cats suffering from FIP.
- 20 February 2024
- Published by American Society for Microbiology in Journal of Virology
- Vol. 98 (2) , e0121623
Open AccessAn RNA replicon system to investigate promising inhibitors of feline coronavirus
FIPV is of great significance in the cat population around the world, causing 0.3%–1.4% of feline deaths in veterinary practices (2). As there are neither effective preventive measures nor approved treatment options available, there is an urgent need to identify antiviral drugs against FIPV. Our FCoV replicon system provides a valuable tool for drug discovery in vitro . Due to the lack of cell culture systems for serotype I FCoVs (the serotype most prevalent in the feline population) (2), a different system is needed to study these viruses. A viral replicon system is a valuable tool for studying FCoVs. Overall, our results demonstrate the utility of the serotype I feline coronavirus replicon system for antiviral screening as well as to study this virus in general. We propose several compounds representing promising candidates for future clinical trials and ultimately with the potential to save cats suffering from FIP.
- Top Cited Papers
- 15 January 2024
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 22 (4) , 206-225
SARS-CoV-2 biology and host interactions
The zoonotic emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the ensuing coronavirus disease 2019 (COVID-19) pandemic have profoundly affected our society. The rapid spread and continuous evolution of new SARS-CoV-2 variants continue to threaten global public health. Recent scientific advances have dissected many of the molecular and cellular mechanisms involved in coronavirus infections, and large-scale screens have uncovered novel host-cell factors that are vitally important for the virus life cycle. In this Review, we provide an updated summary of the SARS-CoV-2 life cycle, gene function and virus–host interactions, including recent landmark findings on general aspects of coronavirus biology and newly discovered host factors necessary for virus replication.
- 15 January 2024
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 22 (4) , 206-225
Top Cited PapersSARS-CoV-2 biology and host interactions
The zoonotic emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the ensuing coronavirus disease 2019 (COVID-19) pandemic have profoundly affected our society. The rapid spread and continuous evolution of new SARS-CoV-2 variants continue to threaten global public health. Recent scientific advances have dissected many of the molecular and cellular mechanisms involved in coronavirus infections, and large-scale screens have uncovered novel host-cell factors that are vitally important for the virus life cycle. In this Review, we provide an updated summary of the SARS-CoV-2 life cycle, gene function and virus–host interactions, including recent landmark findings on general aspects of coronavirus biology and newly discovered host factors necessary for virus replication.